
FDA grants accelerated approval of tofersen for treatment of SOD1-ALS
The Food and Drug Administration granted accelerated approval of the drug tofersen for the treatment of SOD1-ALS. Developed by…
The Food and Drug Administration granted accelerated approval of the drug tofersen for the treatment of SOD1-ALS. Developed by…
In a new paper in PLOS Genetics, Packard researcher Jiou Wang identified a new mechanism through which C9orf72…
Answer ALS Launches ‘The Data is Here’ Campaign to Announce the Release of the World’ Largest Open-Sourced ALS…
Packard researchers used Answer ALS cell lines to show that the protein CHMP7 accumulates in the nucleus, triggering…
Every year, 5,000 Americans are diagnosed with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, that…